Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)

Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)

Background: For the patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) for at least 1 year is recommended in the guidelines to minimize the risk of stent thrombosis. Persistently uncovered stent strut means delayed neoint...

Full description

Bibliographic Details
Main Authors: Zheng Yin, Zhi-Fan Li, Wen-Jia Zhang, Shuang Zhang, Yong-Gang Sui, Yan-Lu Xu, Hai-Tao Zhang, Xiao-Ning Liu, Hong Qiu, Jing-Lin Zhao, Jian-Jun Li, Ke-Fei Dou, Jie Qian, Yong-Jian Wu, Na-Qiong Wu
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Heliyon
Subjects:
Acute coronary syndrome
PCSK9mAb
LDL-C
Stent strut endothelial coverage
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023094306

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023094306

Similar Items